Study of ML-016 for advanced cancer in lung or liver
Part of Cancer clinical trials.
This trial tests a new drug, ML-016, for people with advanced solid tumors that have spread to the lungs or liver and haven't responded to standard treatments. It aims to see if the drug can help shrink tumors or stop them from growing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have advanced solid tumor cancer that has spread to your lungs or liver.
- You can walk and take care of yourself (ECOG score 0 or 1).
- Your blood counts, kidney function, and liver function are within certain limits.
- You have not had cancer treatment or major surgery in the past 2-4 weeks.
- You are willing to use effective contraception if you could become pregnant or cause pregnancy.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an experimental drug called LM-350 for people with advanced solid tumors that have not responded to other treatments. The goal is to see if the drug can shrink tumors or slow their growth.
This trial tests a combination of two experimental drugs (LB1410 and LB4330) in people with advanced or metastatic solid tumors that have stopped responding to standard treatments or where no standard treatment exists. It aims to see if this combination can shrink tumors or slow their growth.
This trial tests a new drug called LPM6690176 for people with advanced solid tumors that have not responded to standard treatments. The goal is to see if it is safe and how it affects the body.
This trial tests an experimental drug called MHB046C for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if it can shrink tumors or slow their growth.
This trial tests a new medication for people with advanced solid tumors that have stopped responding to standard treatments. It aims to see if the drug can shrink tumors or slow their growth.
This trial tests a new drug called LM-168, either alone or combined with another cancer treatment, for people with advanced solid tumors that have not responded to standard therapies. The goal is to see if it can shrink tumors or slow their growth.
Hear when a new Advanced Solid Tumor With Lung and/or Liver Involvement trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.